Cullinan Associates’s MetLife MET Stock Holding History

Cullinan Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,308	Closed	-$261K	–	216
2025 Q4	$261K	Buy	3,308 +200	+6%	+$15.8K	0.02%	199
2025 Q3	$256K	Buy	3,108 +100	+3%	+$7.87K	0.02%	200
2025 Q2	$242K	Sell	3,008 -3,236	-52%	-$250K	0.02%	202
2025 Q1	$501K	Sell	6,244 -68	-1%	-$5.66K	0.04%	162
2024 Q4	$517K	Hold	6,312	–	–	0.03%	169
2024 Q3	$536K	Sell	6,312 -263	-4%	-$19.6K	0.03%	174
2024 Q2	$461K	Sell	6,575 -29,192	-82%	-$2.08M	0.03%	188
2024 Q1	$2.65M	Sell	35,767 -136,502	-79%	-$9.51M	0.15%	106
2023 Q4	$11.4M	Sell	172,269 -33,891	-16%	-$2.12M	0.64%	35
2023 Q3	$13M	Buy	206,160 +22,439	+12%	+$1.4M	0.76%	30
2023 Q2	$10.4M	Sell	183,721 -14,002	-7%	-$777K	0.57%	49
2023 Q1	$11.5M	Buy	197,723 +18,862	+11%	+$1.27M	0.67%	42
2022 Q4	$12.9M	Buy	178,861 +4,144	+2%	+$297K	0.72%	30
2022 Q3	$10.6M	Buy	174,717 +9,528	+6%	+$609K	0.67%	42
2022 Q2	$10.4M	Buy	165,189 +7,856	+5%	+$520K	0.63%	45
2022 Q1	$11.1M	Buy	157,333 +15,560	+11%	+$1.05M	0.58%	50
2021 Q4	$8.86M	Buy	141,773 +17,089	+14%	+$1.07M	0.45%	64
2021 Q3	$7.7M	Buy	124,684 +95,534	+328%	+$5.75M	0.43%	69
2021 Q2	$1.75M	Buy	29,150 +22,500	+338%	+$1.43M	0.1%	123
2021 Q1	$404K	Sell	6,650 -101,000	-94%	-$5.57M	0.02%	171
2020 Q4	$5.05M	Sell	107,650 -7,801	-7%	-$338K	0.3%	85
2020 Q3	$4.29M	Sell	115,451 -4,000	-3%	-$152K	0.28%	88
2020 Q2	$4.36M	Sell	119,451 -2,002	-2%	-$69.7K	0.31%	86
2020 Q1	$3.71M	Buy	121,453 +7,952	+7%	+$353K	0.3%	84
2019 Q4	$5.79M	Buy	113,501 +7,524	+7%	+$363K	0.39%	73
2019 Q3	$5M	Buy	105,977 +6,477	+7%	+$309K	0.36%	75
2019 Q2	$4.94M	Sell	99,500 -350	-0.4%	-$16.5K	0.36%	78
2019 Q1	$4.25M	Buy	99,850 +1,650	+2%	+$73K	0.32%	88
2018 Q4	$4.03M	Sell	98,200 -8,500	-8%	-$365K	0.33%	78
2018 Q3	$4.99M	Sell	106,700 -6,200	-5%	-$283K	0.36%	78
2018 Q2	$4.92M	Sell	112,900 -5,100	-4%	-$238K	0.38%	75
2018 Q1	$5.42M	Buy	118,000 +2,550	+2%	+$124K	0.41%	66
2017 Q4	$5.84M	Buy	115,450 +25,650	+29%	+$1.35M	0.43%	65
2017 Q3	$4.67M	Sell	89,800 -1,194	-1%	-$58.1K	0.36%	74
2017 Q2	$4.46M	Buy	90,994 +2,463	+3%	+$114K	0.35%	79
2017 Q1	$4.17M	Sell	88,531 -5,835	-6%	-$278K	0.34%	80
2016 Q4	$4.53M	Sell	94,366 -7,181	-7%	-$329K	0.39%	70
2016 Q3	$4.02M	Buy	101,547 +343	+0.3%	+$12.9K	0.34%	81
2016 Q2	$3.59M	Sell	101,204 -1,683	-2%	-$65.6K	0.29%	87
2016 Q1	$4.03M	Buy	102,887 +9,400	+10%	+$351K	0.34%	77
2015 Q4	$4.02M	Buy	93,487 +42,832	+85%	+$1.88M	0.35%	73
2015 Q3	$2.13M	Buy	50,655 +43,337	+592%	+$2.02M	0.19%	101
2015 Q2	$365K	Hold	7,318	–	–	0.03%	187
2015 Q1	$330K	Buy	+7,318	New	+$329K	0.03%	192

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cullinan Associates's MET Position: Q1 2026 in Review

Cullinan Associates sold out of MetLife (MET) in Q1 2026, closing a stake of 3,308 shares — an estimated $261K sold.

Cullinan Associates first reported a position in MET in Q1 2015 and held it in 44 quarters. The position peaked at $13M in Q3 2023. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Cullinan Associates reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
Cullinan Associates sold 3,308 MetLife shares in Q1 2026, an estimated $261K.
Cullinan Associates first reported a position in MetLife in Q1 2015 and held it in 44 quarters.
Cullinan Associates's MetLife position peaked at $13M in Q3 2023.
1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.